This program is specifically designed for HIV healthcare professionals based in Europe.

We offer a similar program for American HIV physicians.

For the US edition website please, click here.

Despite improved antiretroviral regimens, virologic failure and the emergence of drug resistance remains an ongoing challenge throughout Europe. This includes both patients recently infected as well as those veterans of older regimens. Although the resources, diagnostics, and soon drugs, required for improved care of complex patients are now available in many parts of Europe, there remains a knowledge gap in how to best use them. Acquiring and interpreting resistance data correctly, incorporating co-morbidities and co-medications data, and then deciding on the optimal next regimen for patients with limited treatment options requires a high level of expertise. These complex HIV patients require greater knowledge and understanding to manage in terms of adherence, resistance, aging, comorbidities, and polypharmacy.

This Webinar has been designed for European HIV physicians who would like to improve their knowledge of identifying and managing patients with limited treatment options, as well as new antiretroviral drugs for optimizing treatment of these patients.

Join our interactive 3-hour Webinar on 24 November 2020 at 15:00 CEST and get the most up-to-date information from international experts.

Tuesday 24 November 2020

15:00 CEST


  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
Jonathan Schapiro MD

Sheba Medical Center

Tel Aviv, Israel


This activity is intended for all European health care professionals actively involved in caring for HIV infected individuals, as some patients in their clinic will have limited treatment options and require management as complex patients.



  • European HIV physicians experienced in treating complex HIV patients who need to be informed and updated on new treatment options;

  • European HIV physicians inexperienced in treating complex HIV patients who need more comprehensive education on identifying and managing complex patients with an emphasis on new drugs;

  • European Clinical pharmacologists involved in the concomitant medication management and dose adjusting for co-morbidities of the complex HIV patient;

  • Other European Health Care Professionals (e.g. nurse practitioners) intimately involved in the medical care of complex patients.



At the completion of the symposium participants will have:

  • Improved knowledge of the definition on complex patients and the challenges of their care;

  • Acquired tools and understanding on how best to Identify the complex HIV patient in their clinical practice;

  • Greater understanding of the new treatment options available for these patients, including recently presented clinical trials.

  • Learned how best to integrate these new drugs into optimal combination regimens for complex patients, considering their local country setting.;

  • Improved skills in managing drug-drug interactions and toxicities in these complex patients.

15:00 CEST
Opening of the Webinar; welcome and goals by the Chair
Jonathan Schapiro MD

Sheba Medical Centre

Tel Aviv, Israel

15:05 CEST
How to identify the complex HIV patient & approach to treatment
Daniel Kuritzkes MD

Brigham and Women's Hospital/ Harvard Medical School

Boston, United States

15:20 CEST
Drug options for the complex HIV patient, what are they and how best to use them
Chloe Orkin MBChB, FRCP, MD

Barts Health NHS Trust

London, United Kingdom

16:55 CEST
Managing toxicity in the complex HIV patient
Laura Waters MD, FRCP

Central & North West London NHS Trust

London, United Kingdom

15:40 CEST
Understanding and managing multi-class resistance
Anton Pozniak MD, FRCP

Chelsea and Westminster Hospital

London, United Kingdom

15:55 CEST
Clinical case: Focus on drug resistance
Milosz Parczewski MD, PhD

Pomeranian Medical University

Szczecin, Poland

16:10 CEST
Discussion and Q/A with all speakers: How to design an optimal regimen for the complex patient
16:25 CEST
Short Break
16:35 CEST
Pharmacological considerations in the complex HIV patient
Marta Boffito MD, PhD, FRCP

Chelsea and Westminster Hospital

London, United Kingdom

17:15 CEST
Clinical case: Focus on co-morbidities and toxicity
Josep Maria Llibre MD, PhD

Hospital Universitari Germans Trias i Pujol

Badalona, Spain

17:30 CEST
Discussion and Q/A with all speakers: How to manage Toxicity and Drug Interactions in the complex patient
17:50 CEST
Closure of the Webinar
Jonathan Schapiro MD

Sheba Medical Centre

Tel Aviv, Israel

If you have any questions please contact Patrick Conings at

In order to access this webinar, you must register online. Registration to the Managing HIV Complex Patients Webinar - European Edition is free of charge for all healthcare practitioners*. A registration fee applies to other individuals.

*Healthcare practitioners are defined as professionals that provide a type of health care service to patients living with HIV. Please, contact the Conference Secretariat for more information at if you are not sure.


Managing Complex HIV Patients – European Edition is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Biltstraat 106

3572 BJ, Utrecht, the Netherlands

  • White Twitter Icon
  • White LinkedIn Icon
  • White Facebook Icon

Tel: +31 (0)30 230 7140

© 2020 by Virology Education